{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/390654082"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "We have an agreeement to develop ZFP Therapeutics for hemophilia, Huntington's disease and other monogenic diseases with Shire AG. We are also developing ZFP-based medicines for our own pipeline in HIV/AIDS and monogenic diseases such as hemoglobinopathies and lysosomal storage disorders." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "sangamo.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/341410398"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/390654082" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/234765520"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/390654082"] } } }
